New diagnostic method for liver fibrosis and cirrhosis

KwangHyub Han, Ki Tae Yoon

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Liver fibrosis, i.e. excessive accumulation of extracellular matrix proteins, occurs in most types of chronic liver diseases. The prognosis and management of chronic liver diseases depend on the degree of liver fibrosis. Therefore, the assessment of liver fibrosis provides useful information not only for diagnosis but also for treatment planning. Although liver biopsy is still the gold standard for assessing hepatic fibrosis, it has some technical limitations and risks. Furthermore, the dynamic process of liver fibrosis resulting from progression and regression cannot be quantified by liver biopsy. Therefore, alternative, simple, reliable and noninvasive tests are needed to assess the stage of fibrosis. Several noninvasive direct and indirect serum markers able to predict the presence of significant fibrosis or cirrhosis in patients with chronic liver disease with considerable accuracy have been reported. However, since most of these markers require complicated calculations, clinical application is difficult. Transient elastography (FibroScan®) is a new method for the evaluation of liver stiffness. The technique is based on changes in tissue elasticity induced by hepatic fibrosis. Liver stiffness measured by transient elastography is a noninvasive, reproducible and reliable method to assess hepatic fibrosis as well as to diagnose liver cirrhosis. Based on accumulating clinical data, clinical applications of elastography will increase in the near future.

Original languageEnglish
Pages (from-to)11-16
Number of pages6
JournalIntervirology
Volume51
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2008 Jun 1

Fingerprint

Liver Cirrhosis
Fibrosis
Liver
Elasticity Imaging Techniques
Liver Diseases
Chronic Disease
Biopsy
Extracellular Matrix Proteins
Elasticity
Biomarkers

All Science Journal Classification (ASJC) codes

  • Virology
  • Infectious Diseases

Cite this

Han, KwangHyub ; Yoon, Ki Tae. / New diagnostic method for liver fibrosis and cirrhosis. In: Intervirology. 2008 ; Vol. 51, No. SUPPL. 1. pp. 11-16.
@article{b7ed94dd60824aa2889115d988e9cd22,
title = "New diagnostic method for liver fibrosis and cirrhosis",
abstract = "Liver fibrosis, i.e. excessive accumulation of extracellular matrix proteins, occurs in most types of chronic liver diseases. The prognosis and management of chronic liver diseases depend on the degree of liver fibrosis. Therefore, the assessment of liver fibrosis provides useful information not only for diagnosis but also for treatment planning. Although liver biopsy is still the gold standard for assessing hepatic fibrosis, it has some technical limitations and risks. Furthermore, the dynamic process of liver fibrosis resulting from progression and regression cannot be quantified by liver biopsy. Therefore, alternative, simple, reliable and noninvasive tests are needed to assess the stage of fibrosis. Several noninvasive direct and indirect serum markers able to predict the presence of significant fibrosis or cirrhosis in patients with chronic liver disease with considerable accuracy have been reported. However, since most of these markers require complicated calculations, clinical application is difficult. Transient elastography (FibroScan{\circledR}) is a new method for the evaluation of liver stiffness. The technique is based on changes in tissue elasticity induced by hepatic fibrosis. Liver stiffness measured by transient elastography is a noninvasive, reproducible and reliable method to assess hepatic fibrosis as well as to diagnose liver cirrhosis. Based on accumulating clinical data, clinical applications of elastography will increase in the near future.",
author = "KwangHyub Han and Yoon, {Ki Tae}",
year = "2008",
month = "6",
day = "1",
doi = "10.1159/000122594",
language = "English",
volume = "51",
pages = "11--16",
journal = "Intervirology",
issn = "0300-5526",
publisher = "S. Karger AG",
number = "SUPPL. 1",

}

New diagnostic method for liver fibrosis and cirrhosis. / Han, KwangHyub; Yoon, Ki Tae.

In: Intervirology, Vol. 51, No. SUPPL. 1, 01.06.2008, p. 11-16.

Research output: Contribution to journalArticle

TY - JOUR

T1 - New diagnostic method for liver fibrosis and cirrhosis

AU - Han, KwangHyub

AU - Yoon, Ki Tae

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Liver fibrosis, i.e. excessive accumulation of extracellular matrix proteins, occurs in most types of chronic liver diseases. The prognosis and management of chronic liver diseases depend on the degree of liver fibrosis. Therefore, the assessment of liver fibrosis provides useful information not only for diagnosis but also for treatment planning. Although liver biopsy is still the gold standard for assessing hepatic fibrosis, it has some technical limitations and risks. Furthermore, the dynamic process of liver fibrosis resulting from progression and regression cannot be quantified by liver biopsy. Therefore, alternative, simple, reliable and noninvasive tests are needed to assess the stage of fibrosis. Several noninvasive direct and indirect serum markers able to predict the presence of significant fibrosis or cirrhosis in patients with chronic liver disease with considerable accuracy have been reported. However, since most of these markers require complicated calculations, clinical application is difficult. Transient elastography (FibroScan®) is a new method for the evaluation of liver stiffness. The technique is based on changes in tissue elasticity induced by hepatic fibrosis. Liver stiffness measured by transient elastography is a noninvasive, reproducible and reliable method to assess hepatic fibrosis as well as to diagnose liver cirrhosis. Based on accumulating clinical data, clinical applications of elastography will increase in the near future.

AB - Liver fibrosis, i.e. excessive accumulation of extracellular matrix proteins, occurs in most types of chronic liver diseases. The prognosis and management of chronic liver diseases depend on the degree of liver fibrosis. Therefore, the assessment of liver fibrosis provides useful information not only for diagnosis but also for treatment planning. Although liver biopsy is still the gold standard for assessing hepatic fibrosis, it has some technical limitations and risks. Furthermore, the dynamic process of liver fibrosis resulting from progression and regression cannot be quantified by liver biopsy. Therefore, alternative, simple, reliable and noninvasive tests are needed to assess the stage of fibrosis. Several noninvasive direct and indirect serum markers able to predict the presence of significant fibrosis or cirrhosis in patients with chronic liver disease with considerable accuracy have been reported. However, since most of these markers require complicated calculations, clinical application is difficult. Transient elastography (FibroScan®) is a new method for the evaluation of liver stiffness. The technique is based on changes in tissue elasticity induced by hepatic fibrosis. Liver stiffness measured by transient elastography is a noninvasive, reproducible and reliable method to assess hepatic fibrosis as well as to diagnose liver cirrhosis. Based on accumulating clinical data, clinical applications of elastography will increase in the near future.

UR - http://www.scopus.com/inward/record.url?scp=44949155376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44949155376&partnerID=8YFLogxK

U2 - 10.1159/000122594

DO - 10.1159/000122594

M3 - Article

VL - 51

SP - 11

EP - 16

JO - Intervirology

JF - Intervirology

SN - 0300-5526

IS - SUPPL. 1

ER -